Spire Wealth Management’s GSK GSK Stock Holding History

Spire Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$90.6K	Sell	1,729 -24	-1%	-$1.27K	﹤0.01%	1007
2026 Q1	$96.7K	Sell	1,753 -514	-23%	-$27.9K	﹤0.01%	968
2025 Q4	$111K	Buy	2,267 +317	+16%	+$14.8K	﹤0.01%	961
2025 Q3	$84.2K	Sell	1,950 -148	-7%	-$5.78K	﹤0.01%	1049
2025 Q2	$80.6K	Sell	2,098 -126	-6%	-$4.82K	﹤0.01%	1046
2025 Q1	$86.1K	Sell	2,224 -40	-2%	-$1.46K	﹤0.01%	1088
2024 Q4	$76.6K	Buy	+2,264	New	+$81.5K	﹤0.01%	1134
2022 Q3	–	Sell	-7,912	Closed	-$431K	–	2354
2022 Q2	$431K	Sell	7,912 -1,444	-15%	-$79.7K	0.02%	517
2022 Q1	$509K	Sell	9,356 -2,027	-18%	-$110K	0.01%	568
2021 Q4	$628K	Buy	11,383 +1,589	+16%	+$82.7K	0.01%	612
2021 Q3	$468K	Buy	9,794 +1,259	+15%	+$63.2K	0.01%	605
2021 Q2	$425K	Sell	8,535 -4,110	-33%	-$197K	0.01%	656
2021 Q1	$566K	Buy	+12,645	New	+$574K	0.02%	627

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Spire Wealth Management's GSK Position: Q2 2026 in Review

Spire Wealth Management reduced its GSK (GSK) stake by 1.4% in Q2 2026, selling an estimated $1.27K and leaving 1,729 shares worth $90.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

Spire Wealth Management first reported a position in GSK in Q1 2021 and has held it in 13 quarters since. The position peaked at $628K in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Spire Wealth Management held 1,729 shares of GSK worth $90.6K as of Q2 2026.
Spire Wealth Management sold 24 GSK shares in Q2 2026, an estimated $1.27K.
GSK made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1007 holding.
Spire Wealth Management first reported a position in GSK in Q1 2021 and has held it in 13 quarters since.
Spire Wealth Management's GSK position peaked at $628K in Q4 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.